(Beijing Comprehensive News) After abandoning the zero -prevention and clearing policy for more than three months, China has approved the first domestic coronary vaccine that uses messenger nucleotanic acid (mRNA) technology.
Stone medicine: Group MRNA vaccine is incorporated into China in China
Comprehensive interface news and Bloomberg reported that the Stone Medicine Group announced on Wednesday (March 22) on the Hong Kong Stock Exchange that the group's MRNA vaccine was included in China in China to prevent diseases caused by crown disease infections.The Group also said that this is China's first MRNA vaccine to independently develop and obtain emergency authorization.
China relaxed crown disease prevention restrictions in December 2022.But whether before or after, the official has not approved the use of foreign and domestic MRNA vaccines widely in mainland China.
China has not adopted the MRNA vaccine for a long time, and was regarded by the outside world as one of the reasons for the country's loose prevention policy to cause large -scale infection.Most Chinese people's injecting vaccines cannot prevent the spread of crown diseases.
According to Reuters in early February, there are more than 10 companies in China's layout of MRNA vaccines, and at least eight MRNA vaccines have entered the clinical trial stage.
